Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 2
2003 2
2004 1
2005 3
2006 3
2007 2
2008 4
2009 4
2011 4
2012 2
2013 4
2014 10
2015 11
2016 6
2017 12
2018 10
2019 10
2020 11
2021 8
2022 10
2023 15
2024 11
2025 19
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Amyotrophic lateral sclerosis: a clinical review.
Masrori P, Van Damme P. Masrori P, et al. Eur J Neurol. 2020 Oct;27(10):1918-1929. doi: 10.1111/ene.14393. Epub 2020 Jul 7. Eur J Neurol. 2020. PMID: 32526057 Free PMC article. Review.
These expansions are also a frequent cause of frontotemporal dementia, emphasizing the molecular overlap between ALS and FTD. To this day there is no cure or effective treatment for ALS and the cornerstone of treatment remains multidisciplinary care, i …
These expansions are also a frequent cause of frontotemporal dementia, emphasizing the molecular overlap between ALS and FTD. To this …
Amyotrophic lateral sclerosis: disease state overview.
Hulisz D. Hulisz D. Am J Manag Care. 2018 Aug;24(15 Suppl):S320-S326. Am J Manag Care. 2018. PMID: 30207670 Free article. Review.
ALS affects approximately 16,000 individuals, with a prognosis for survival of 2 to 5 years. There are 2 types of ALS differentiated by genetics: familial and sporadic (idiopathic). Diagnosis is determined by excluding other conditions and utilizing clinic …
ALS affects approximately 16,000 individuals, with a prognosis for survival of 2 to 5 years. There are 2 types of ALS d …
Respiratory Failure in Amyotrophic Lateral Sclerosis.
Niedermeyer S, Murn M, Choi PJ. Niedermeyer S, et al. Chest. 2019 Feb;155(2):401-408. doi: 10.1016/j.chest.2018.06.035. Epub 2018 Jul 7. Chest. 2019. PMID: 29990478 Review.
Amyotrophic lateral sclerosis is a progressive neuromuscular disease characterized by both lower motor neuron and upper motor neuron dysfunction. Although clinical presentations can vary, there is no cure for ALS, and the disease is universally terminal, with most p …
Amyotrophic lateral sclerosis is a progressive neuromuscular disease characterized by both lower motor neuron and upper motor neuron dysfunc …
Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study.
Hobin F, De Vocht J, Lamaire N, Beyens H, Ombelet F, Van Damme P. Hobin F, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):282-289. doi: 10.1080/21678421.2024.2304058. Epub 2024 Jan 19. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38240367 Free article.
The average survival time is 2-5 years, mostly due to respiratory failure. Since current therapies can prolong survival time by only a few months, multidisciplinary care remains the cornerstone of the management of ALS. ...We included 659 patien …
The average survival time is 2-5 years, mostly due to respiratory failure. Since current therapies can prolong survival time b …
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
Witzel S, Maier A, Steinbach R, Grosskreutz J, Koch JC, Sarikidi A, Petri S, Günther R, Wolf J, Hermann A, Prudlo J, Cordts I, Lingor P, Löscher WN, Kohl Z, Hagenacker T, Ruckes C, Koch B, Spittel S, Günther K, Michels S, Dorst J, Meyer T, Ludolph AC; German Motor Neuron Disease Network (MND-NET). Witzel S, et al. JAMA Neurol. 2022 Feb 1;79(2):121-130. doi: 10.1001/jamaneurol.2021.4893. JAMA Neurol. 2022. PMID: 35006266 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate the long-term safety and effectiveness of intravenous edaravone therapy for patients with ALS in a real-world clinical setting. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, propensity score-matched cohort study conducted between June 2017 a …
OBJECTIVE: To evaluate the long-term safety and effectiveness of intravenous edaravone therapy for patients with ALS in a real-world …
[Multidisciplinary care and therapeutic advances in amyotrophic lateral sclerosis].
Matamala JM, Moreno-Roco J, Acosta I, Hughes R, Lillo P, Casar JC, Earle N. Matamala JM, et al. Rev Med Chil. 2022 Dec;150(12):1633-1646. doi: 10.4067/s0034-98872022001201633. Rev Med Chil. 2022. PMID: 37906785 Free article. Spanish.
Despite the tremendous advances in physiopathological and clinical characterization, we do not have a curative treatment yet. The progressive and fatal course of ALS makes its management particularly complex and challenging given the diversity of symptoms presenting …
Despite the tremendous advances in physiopathological and clinical characterization, we do not have a curative treatment yet. The pro …
Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Chronic Kidney Disease Collaborators. GBD 2023 Chronic Kidney Disease Collaborators. Lancet. 2025 Nov 22;406(10518):2461-2482. doi: 10.1016/S0140-6736(25)01853-7. Epub 2025 Nov 7. Lancet. 2025. PMID: 41213283 Free article.
BACKGROUND: Chronic kidney disease (CKD) is common and ranks among the leading causes of mortality and morbidity. This analysis aimed to present global CKD estimates using the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 to inform evidence-based p …
BACKGROUND: Chronic kidney disease (CKD) is common and ranks among the leading causes of mortality and morbidity. This analysis aimed …
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.
Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G. Zoccolella S, et al. J Neurol. 2007 Aug;254(8):1107-12. doi: 10.1007/s00415-006-0401-y. Epub 2007 Apr 13. J Neurol. 2007. PMID: 17431705
Because of the multifactorial nature of impairment and disablity in ALS, multidisciplinary clinics (MDC) have been recently introduced in the management of ALS patients; their effects on survival remain, however, largely debated. OBJECTIVE: To c …
Because of the multifactorial nature of impairment and disablity in ALS, multidisciplinary clinics (MDC) have been rece …
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
To ensure human wellbeing, economic stability, and social equity, global action to sustain and advance health gains must prioritise reducing disparities by addressing socioeconomic and demographic determinants, ensuring equitable health-care access, tackling malnutrition, …
To ensure human wellbeing, economic stability, and social equity, global action to sustain and advance health gains must prioritise reducing …
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.
Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, Hardiman O. Rooney J, et al. J Neurol Neurosurg Psychiatry. 2015 May;86(5):496-501. doi: 10.1136/jnnp-2014-309601. Epub 2014 Dec 30. J Neurol Neurosurg Psychiatry. 2015. PMID: 25550416
RESULTS: A survival benefit was identified for patients who attended the multidisciplinary ALS clinic in the RoI. ...CONCLUSIONS: Centralised multidisciplinary care confers a survival advantage for patients with ALS and is s …
RESULTS: A survival benefit was identified for patients who attended the multidisciplinary ALS clinic in the RoI …
155 results